NCT02491905View on ClinicalTrials.gov

Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

HL tablet

DRUG

Placebo

Trial Locations (1)

426791

Huons, Ansan

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY

NCT02491905 - Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients | Biotech Hunter | Biotech Hunter